nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4C—tongue—hypothyroidism	0.0372	0.08	CbGeAlD
Flavoxate—PDE7B—heart—hypothyroidism	0.0192	0.0412	CbGeAlD
Flavoxate—Tachycardia—Liothyronine—hypothyroidism	0.0162	0.0729	CcSEcCtD
Flavoxate—PDE8B—heart—hypothyroidism	0.0153	0.0328	CbGeAlD
Flavoxate—PDE7B—adrenal gland—hypothyroidism	0.0143	0.0308	CbGeAlD
Flavoxate—PDE8A—adrenal cortex—hypothyroidism	0.0142	0.0305	CbGeAlD
Flavoxate—PDE7B—thyroid gland—hypothyroidism	0.0138	0.0297	CbGeAlD
Flavoxate—PDE8A—heart—hypothyroidism	0.0137	0.0295	CbGeAlD
Flavoxate—PDE8B—gonad—hypothyroidism	0.0131	0.0281	CbGeAlD
Flavoxate—PDE4D—heart—hypothyroidism	0.0124	0.0268	CbGeAlD
Flavoxate—PDE7B—testis—hypothyroidism	0.0118	0.0255	CbGeAlD
Flavoxate—PDE8A—pituitary gland—hypothyroidism	0.0115	0.0247	CbGeAlD
Flavoxate—PDE8B—adrenal gland—hypothyroidism	0.0114	0.0245	CbGeAlD
Flavoxate—PDE7B—liver—hypothyroidism	0.0112	0.0241	CbGeAlD
Flavoxate—PDE4A—heart—hypothyroidism	0.011	0.0237	CbGeAlD
Flavoxate—PDE8B—thyroid gland—hypothyroidism	0.011	0.0237	CbGeAlD
Flavoxate—PDE8A—adrenal gland—hypothyroidism	0.0102	0.022	CbGeAlD
Flavoxate—PDE8A—blood—hypothyroidism	0.0102	0.022	CbGeAlD
Flavoxate—PDE8A—thyroid gland—hypothyroidism	0.00989	0.0213	CbGeAlD
Flavoxate—Tension—Levothyroxine—hypothyroidism	0.00983	0.0441	CcSEcCtD
Flavoxate—Tension—Dextrothyroxine—hypothyroidism	0.00983	0.0441	CcSEcCtD
Flavoxate—Nervousness—Levothyroxine—hypothyroidism	0.00973	0.0436	CcSEcCtD
Flavoxate—Nervousness—Dextrothyroxine—hypothyroidism	0.00973	0.0436	CcSEcCtD
Flavoxate—PDE8A—female gonad—hypothyroidism	0.00955	0.0206	CbGeAlD
Flavoxate—PDE8B—testis—hypothyroidism	0.00942	0.0203	CbGeAlD
Flavoxate—PDE4D—adrenal gland—hypothyroidism	0.00928	0.02	CbGeAlD
Flavoxate—PDE4D—thyroid gland—hypothyroidism	0.00896	0.0193	CbGeAlD
Flavoxate—PDE8B—liver—hypothyroidism	0.0089	0.0192	CbGeAlD
Flavoxate—Palpitations—Dextrothyroxine—hypothyroidism	0.00885	0.0397	CcSEcCtD
Flavoxate—Palpitations—Levothyroxine—hypothyroidism	0.00885	0.0397	CcSEcCtD
Flavoxate—PDE8B—cerebellum—hypothyroidism	0.0087	0.0187	CbGeAlD
Flavoxate—PDE4D—female gonad—hypothyroidism	0.00866	0.0186	CbGeAlD
Flavoxate—PDE8A—testis—hypothyroidism	0.00847	0.0182	CbGeAlD
Flavoxate—Confusional state—Levothyroxine—hypothyroidism	0.00824	0.037	CcSEcCtD
Flavoxate—Confusional state—Dextrothyroxine—hypothyroidism	0.00824	0.037	CcSEcCtD
Flavoxate—PDE4A—adrenal gland—hypothyroidism	0.00822	0.0177	CbGeAlD
Flavoxate—PDE8A—liver—hypothyroidism	0.00801	0.0172	CbGeAlD
Flavoxate—Tachycardia—Levothyroxine—hypothyroidism	0.00798	0.0358	CcSEcCtD
Flavoxate—Tachycardia—Dextrothyroxine—hypothyroidism	0.00798	0.0358	CcSEcCtD
Flavoxate—PDE4A—thyroid gland—hypothyroidism	0.00793	0.0171	CbGeAlD
Flavoxate—PDE8A—cerebellum—hypothyroidism	0.00783	0.0168	CbGeAlD
Flavoxate—PDE4D—testis—hypothyroidism	0.00768	0.0165	CbGeAlD
Flavoxate—PDE4A—female gonad—hypothyroidism	0.00766	0.0165	CbGeAlD
Flavoxate—PDE4D—liver—hypothyroidism	0.00726	0.0156	CbGeAlD
Flavoxate—Tension—Liotrix—hypothyroidism	0.00723	0.0324	CcSEcCtD
Flavoxate—Nervousness—Liotrix—hypothyroidism	0.00715	0.0321	CcSEcCtD
Flavoxate—PDE4D—cerebellum—hypothyroidism	0.00709	0.0153	CbGeAlD
Flavoxate—Vision blurred—Liotrix—hypothyroidism	0.00694	0.0311	CcSEcCtD
Flavoxate—PDE4A—testis—hypothyroidism	0.00679	0.0146	CbGeAlD
Flavoxate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00673	0.0302	CcSEcCtD
Flavoxate—Feeling abnormal—Levothyroxine—hypothyroidism	0.00673	0.0302	CcSEcCtD
Flavoxate—PDE4B—heart—hypothyroidism	0.00656	0.0141	CbGeAlD
Flavoxate—CHRM2—heart—hypothyroidism	0.00652	0.014	CbGeAlD
Flavoxate—Palpitations—Liotrix—hypothyroidism	0.00651	0.0292	CcSEcCtD
Flavoxate—Urticaria—Dextrothyroxine—hypothyroidism	0.00649	0.0291	CcSEcCtD
Flavoxate—Urticaria—Levothyroxine—hypothyroidism	0.00649	0.0291	CcSEcCtD
Flavoxate—PDE4A—cerebellum—hypothyroidism	0.00628	0.0135	CbGeAlD
Flavoxate—CHRM2—cardiovascular system—hypothyroidism	0.00615	0.0132	CbGeAlD
Flavoxate—Confusional state—Liotrix—hypothyroidism	0.00606	0.0272	CcSEcCtD
Flavoxate—Tachycardia—Liotrix—hypothyroidism	0.00587	0.0263	CcSEcCtD
Flavoxate—PDE4B—gonad—hypothyroidism	0.00562	0.0121	CbGeAlD
Flavoxate—CHRM1—cardiovascular system—hypothyroidism	0.0056	0.012	CbGeAlD
Flavoxate—PDE4B—pituitary gland—hypothyroidism	0.00548	0.0118	CbGeAlD
Flavoxate—Vomiting—Levothyroxine—hypothyroidism	0.0052	0.0233	CcSEcCtD
Flavoxate—Vomiting—Dextrothyroxine—hypothyroidism	0.0052	0.0233	CcSEcCtD
Flavoxate—Headache—Dextrothyroxine—hypothyroidism	0.00512	0.023	CcSEcCtD
Flavoxate—Headache—Levothyroxine—hypothyroidism	0.00512	0.023	CcSEcCtD
Flavoxate—Feeling abnormal—Liotrix—hypothyroidism	0.00495	0.0222	CcSEcCtD
Flavoxate—PDE4B—adrenal gland—hypothyroidism	0.0049	0.0105	CbGeAlD
Flavoxate—PDE4B—blood—hypothyroidism	0.0049	0.0105	CbGeAlD
Flavoxate—Nausea—Dextrothyroxine—hypothyroidism	0.00485	0.0218	CcSEcCtD
Flavoxate—Nausea—Levothyroxine—hypothyroidism	0.00485	0.0218	CcSEcCtD
Flavoxate—Urticaria—Liotrix—hypothyroidism	0.00478	0.0214	CcSEcCtD
Flavoxate—PDE4B—thyroid gland—hypothyroidism	0.00473	0.0102	CbGeAlD
Flavoxate—PDE4B—female gonad—hypothyroidism	0.00457	0.00983	CbGeAlD
Flavoxate—PDE4B—testis—hypothyroidism	0.00405	0.00872	CbGeAlD
Flavoxate—PDE4B—liver—hypothyroidism	0.00383	0.00824	CbGeAlD
Flavoxate—Vomiting—Liotrix—hypothyroidism	0.00382	0.0171	CcSEcCtD
Flavoxate—Headache—Liotrix—hypothyroidism	0.00377	0.0169	CcSEcCtD
Flavoxate—PDE4B—cerebellum—hypothyroidism	0.00374	0.00805	CbGeAlD
Flavoxate—Nausea—Liotrix—hypothyroidism	0.00357	0.016	CcSEcCtD
Flavoxate—PDE8A—Signaling by GPCR—TRH—hypothyroidism	0.00163	0.00522	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—TSHB—hypothyroidism	0.0016	0.00512	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—TSHR—hypothyroidism	0.0016	0.00512	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—TSHB—hypothyroidism	0.0016	0.00512	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—TSHR—hypothyroidism	0.0016	0.00512	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—TRH—hypothyroidism	0.0016	0.00512	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—TRH—hypothyroidism	0.00149	0.00476	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00146	0.00468	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—TSHB—hypothyroidism	0.00145	0.00465	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—TSHB—hypothyroidism	0.00145	0.00465	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—TSHR—hypothyroidism	0.00145	0.00465	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—TSHR—hypothyroidism	0.00145	0.00465	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—TRH—hypothyroidism	0.00145	0.00465	CbGpPWpGaD
Flavoxate—PDE4D—G alpha (s) signalling events—POMC—hypothyroidism	0.00144	0.0046	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—TSHB—hypothyroidism	0.00143	0.00457	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—TSHR—hypothyroidism	0.00143	0.00457	CbGpPWpGaD
Flavoxate—PDE4A—G alpha (s) signalling events—POMC—hypothyroidism	0.00137	0.00438	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—TRH—hypothyroidism	0.00135	0.00432	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—TSHB—hypothyroidism	0.00133	0.00424	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—TSHR—hypothyroidism	0.00133	0.00424	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—TSHB—hypothyroidism	0.00129	0.00415	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—TSHR—hypothyroidism	0.00129	0.00415	CbGpPWpGaD
Flavoxate—PDE4B—G alpha (s) signalling events—POMC—hypothyroidism	0.00126	0.00405	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—TSHB—hypothyroidism	0.0012	0.00385	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—TSHR—hypothyroidism	0.0012	0.00385	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.00112	0.00359	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CLTC—hypothyroidism	0.00111	0.00357	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CLTC—hypothyroidism	0.00111	0.00357	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00107	0.00342	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00105	0.00337	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.001	0.00321	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CLTC—hypothyroidism	0.000993	0.00318	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—VAV3—hypothyroidism	0.000979	0.00313	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—VAV3—hypothyroidism	0.000979	0.00313	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TRH—hypothyroidism	0.000969	0.0031	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TRH—hypothyroidism	0.000963	0.00308	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TRH—hypothyroidism	0.000963	0.00308	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—AVP—hypothyroidism	0.000943	0.00302	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—AVP—hypothyroidism	0.000943	0.00302	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CLTC—hypothyroidism	0.000923	0.00296	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—VAV3—hypothyroidism	0.000889	0.00285	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—VAV3—hypothyroidism	0.000889	0.00285	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TRH—hypothyroidism	0.00088	0.00282	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—VAV3—hypothyroidism	0.000872	0.00279	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TSHB—hypothyroidism	0.000864	0.00277	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TSHR—hypothyroidism	0.000864	0.00277	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TSHB—hypothyroidism	0.000858	0.00275	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TSHB—hypothyroidism	0.000858	0.00275	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TSHR—hypothyroidism	0.000858	0.00275	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TSHR—hypothyroidism	0.000858	0.00275	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TRH—hypothyroidism	0.000858	0.00275	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—AVP—hypothyroidism	0.000856	0.00274	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—AVP—hypothyroidism	0.000856	0.00274	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TRH—hypothyroidism	0.000844	0.0027	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—AVP—hypothyroidism	0.00084	0.00269	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—VAV3—hypothyroidism	0.000811	0.0026	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TRH—hypothyroidism	0.000803	0.00257	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TRH—hypothyroidism	0.000798	0.00255	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—VAV3—hypothyroidism	0.000792	0.00254	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TSHB—hypothyroidism	0.000785	0.00251	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TSHR—hypothyroidism	0.000785	0.00251	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—AVP—hypothyroidism	0.000781	0.0025	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TRH—hypothyroidism	0.000766	0.00245	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—SH2B3—hypothyroidism	0.000765	0.00245	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—SH2B3—hypothyroidism	0.000765	0.00245	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TSHB—hypothyroidism	0.000765	0.00245	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TSHR—hypothyroidism	0.000765	0.00245	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—AVP—hypothyroidism	0.000763	0.00244	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TSHB—hypothyroidism	0.000752	0.00241	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TSHR—hypothyroidism	0.000752	0.00241	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TRH—hypothyroidism	0.000743	0.00238	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000742	0.00237	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—VAV3—hypothyroidism	0.000736	0.00236	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000732	0.00234	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TRH—hypothyroidism	0.000729	0.00234	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TSHB—hypothyroidism	0.000716	0.00229	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TSHR—hypothyroidism	0.000716	0.00229	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TSHB—hypothyroidism	0.000711	0.00228	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TSHR—hypothyroidism	0.000711	0.00228	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—AVP—hypothyroidism	0.00071	0.00227	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TSHB—hypothyroidism	0.000683	0.00219	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TSHR—hypothyroidism	0.000683	0.00219	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—SH2B3—hypothyroidism	0.000682	0.00218	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TRH—hypothyroidism	0.000675	0.00216	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000671	0.00215	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TSHB—hypothyroidism	0.000662	0.00212	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TSHR—hypothyroidism	0.000662	0.00212	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000661	0.00212	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000661	0.00212	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000653	0.00209	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000653	0.00209	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TSHB—hypothyroidism	0.00065	0.00208	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TSHR—hypothyroidism	0.00065	0.00208	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SH2B3—hypothyroidism	0.000634	0.00203	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—POMC—hypothyroidism	0.000627	0.00201	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—POMC—hypothyroidism	0.000627	0.00201	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CLTC—hypothyroidism	0.000602	0.00193	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TSHB—hypothyroidism	0.000602	0.00193	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TSHR—hypothyroidism	0.000602	0.00193	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000588	0.00188	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—POMC—hypothyroidism	0.000569	0.00182	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—POMC—hypothyroidism	0.000569	0.00182	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PRL—hypothyroidism	0.000568	0.00182	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PRL—hypothyroidism	0.000568	0.00182	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.000565	0.00181	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—POMC—hypothyroidism	0.000559	0.00179	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000558	0.00178	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.000555	0.00178	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—VAV3—hypothyroidism	0.000529	0.00169	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000526	0.00168	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—VAV3—hypothyroidism	0.000525	0.00168	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—VAV3—hypothyroidism	0.000525	0.00168	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CLTC—hypothyroidism	0.000524	0.00168	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TRH—hypothyroidism	0.00052	0.00166	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—POMC—hypothyroidism	0.000519	0.00166	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AVP—hypothyroidism	0.000509	0.00163	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—POMC—hypothyroidism	0.000507	0.00162	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AVP—hypothyroidism	0.000506	0.00162	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AVP—hypothyroidism	0.000506	0.00162	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PRL—hypothyroidism	0.000506	0.00162	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000503	0.00161	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000503	0.00161	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CLTC—hypothyroidism	0.000499	0.0016	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000497	0.00159	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000497	0.00159	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—VAV3—hypothyroidism	0.00048	0.00154	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—POMC—hypothyroidism	0.000472	0.00151	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PRL—hypothyroidism	0.00047	0.00151	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VAV3—hypothyroidism	0.000468	0.0015	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TSHB—hypothyroidism	0.000463	0.00148	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TSHR—hypothyroidism	0.000463	0.00148	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AVP—hypothyroidism	0.000462	0.00148	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CLTC—hypothyroidism	0.000461	0.00148	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—VAV3—hypothyroidism	0.00046	0.00147	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TRH—hypothyroidism	0.000453	0.00145	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AVP—hypothyroidism	0.000451	0.00144	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AVP—hypothyroidism	0.000443	0.00142	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—VAV3—hypothyroidism	0.000438	0.0014	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VAV3—hypothyroidism	0.000435	0.00139	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TRH—hypothyroidism	0.000431	0.00138	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AVP—hypothyroidism	0.000422	0.00135	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AVP—hypothyroidism	0.000419	0.00134	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—VAV3—hypothyroidism	0.000418	0.00134	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SH2B3—hypothyroidism	0.000413	0.00132	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—VAV3—hypothyroidism	0.000405	0.0013	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TSHB—hypothyroidism	0.000403	0.00129	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TSHR—hypothyroidism	0.000403	0.00129	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AVP—hypothyroidism	0.000403	0.00129	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TRH—hypothyroidism	0.000399	0.00128	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—VAV3—hypothyroidism	0.000398	0.00127	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AVP—hypothyroidism	0.00039	0.00125	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00039	0.00125	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000385	0.00123	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSHB—hypothyroidism	0.000384	0.00123	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSHR—hypothyroidism	0.000384	0.00123	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AVP—hypothyroidism	0.000383	0.00123	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—VAV3—hypothyroidism	0.000368	0.00118	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SH2B3—hypothyroidism	0.00036	0.00115	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSHB—hypothyroidism	0.000355	0.00114	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSHR—hypothyroidism	0.000355	0.00114	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AVP—hypothyroidism	0.000355	0.00113	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SH2B3—hypothyroidism	0.000342	0.0011	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—POMC—hypothyroidism	0.000338	0.00108	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—POMC—hypothyroidism	0.000336	0.00108	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—POMC—hypothyroidism	0.000336	0.00108	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IGF1—hypothyroidism	0.000323	0.00104	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF1—hypothyroidism	0.000323	0.00104	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000321	0.00103	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000319	0.00102	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SH2B3—hypothyroidism	0.000317	0.00101	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000315	0.00101	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—POMC—hypothyroidism	0.000307	0.000984	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PRL—hypothyroidism	0.000306	0.000981	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—POMC—hypothyroidism	0.0003	0.000959	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000297	0.00095	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—POMC—hypothyroidism	0.000295	0.000943	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000293	0.000938	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.00029	0.000928	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1—hypothyroidism	0.000288	0.000923	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000286	0.000916	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000285	0.000911	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000285	0.000911	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VAV3—hypothyroidism	0.000284	0.000908	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000281	0.000899	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000281	0.000899	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—POMC—hypothyroidism	0.00028	0.000898	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—POMC—hypothyroidism	0.000279	0.000892	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AVP—hypothyroidism	0.000273	0.000874	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1—hypothyroidism	0.000268	0.000858	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—POMC—hypothyroidism	0.000268	0.000856	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PRL—hypothyroidism	0.000267	0.000854	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—POMC—hypothyroidism	0.000259	0.000831	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000259	0.000829	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000258	0.000827	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000258	0.000827	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000256	0.000818	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000255	0.000816	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000255	0.000816	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—hypothyroidism	0.000255	0.000815	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PRL—hypothyroidism	0.000254	0.000813	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VAV3—hypothyroidism	0.000247	0.00079	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AVP—hypothyroidism	0.000238	0.000761	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—hypothyroidism	0.000236	0.000754	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PRL—hypothyroidism	0.000235	0.000752	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VAV3—hypothyroidism	0.000235	0.000752	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AVP—hypothyroidism	0.000226	0.000725	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VAV3—hypothyroidism	0.000217	0.000696	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AVP—hypothyroidism	0.000209	0.00067	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CLTC—hypothyroidism	0.000198	0.000634	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—hypothyroidism	0.000197	0.000631	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000196	0.000626	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000195	0.000623	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—hypothyroidism	0.000182	0.000581	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1—hypothyroidism	0.000175	0.000559	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000174	0.000557	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	0.000172	0.00055	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TRH—hypothyroidism	0.000171	0.000548	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TRH—hypothyroidism	0.000169	0.000541	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	0.000168	0.000537	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	0.000166	0.00053	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	0.000158	0.000506	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—hypothyroidism	0.000158	0.000506	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	0.000156	0.000499	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSHR—hypothyroidism	0.000153	0.000489	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSHB—hypothyroidism	0.000153	0.000489	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AVP—hypothyroidism	0.000152	0.000487	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1—hypothyroidism	0.000152	0.000487	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSHB—hypothyroidism	0.000151	0.000482	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSHR—hypothyroidism	0.000151	0.000482	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—hypothyroidism	0.00015	0.000482	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AVP—hypothyroidism	0.00015	0.000481	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1—hypothyroidism	0.000145	0.000463	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—hypothyroidism	0.000139	0.000446	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	0.000136	0.000435	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	0.000134	0.00043	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1—hypothyroidism	0.000134	0.000429	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	0.000111	0.000357	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	0.00011	0.000352	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—hypothyroidism	0.000101	0.000324	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRL—hypothyroidism	0.000101	0.000323	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—hypothyroidism	9.99e-05	0.00032	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRL—hypothyroidism	9.96e-05	0.000319	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VAV3—hypothyroidism	9.34e-05	0.000299	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VAV3—hypothyroidism	9.22e-05	0.000295	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AVP—hypothyroidism	8.99e-05	0.000288	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AVP—hypothyroidism	8.88e-05	0.000284	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—hypothyroidism	5.98e-05	0.000191	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—hypothyroidism	5.9e-05	0.000189	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—hypothyroidism	5.75e-05	0.000184	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—hypothyroidism	5.68e-05	0.000182	CbGpPWpGaD
